Several biomarkers, such as cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) have been proposed for the diagnosis and therapy of ovarian carcinomas [4,7,9,14,15,16,17,18]. The gene discussed is MUC16; the disease is ovarian carcinoma.